MoonLake Immunotherapeutics ($MLTX)
Filing Information
| Accession Number | 0001213900-26-080869 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
52,448
Total Value
$1,049,960.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jul 21, 2026 | Sale | 50,000 | $20.02 | $1,001,000.00 | 2,714,746 | Indirect | See footnote. | View Details | |
Chief Scientific Officer | Class A ordinary shares, par value $0.0001 per share | โ | Jul 22, 2026 | Sale | 2,448 | $20.00 | $48,960.00 | 2,712,298 | Indirect | See footnote. | View Details |